Greenphire announced it has released new visual analytics functionality for its eClinicalGPS technology
Greenphire, a provider of payment technologies for the clinical trials industry, announced it has released new visual analytics functionality for its eClinicalGPS technology which aims to give clients the tools aggregate strategic data for more effective trial forecasting, planning, tracking, and quantitative assessment.
By linking key cost drivers like subject enrollment and site-level clinical activity to contract and other financial data, clients are able to have a clear picture of their finances in relation to the trial, so they can make more effective business decisions, in real-time, that ensure a trial is completed on-time and on-budget.
For further information on Greenphire and its solutions please email: [email protected] or visit www.greenphire.com.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.